Blow-Fill-Seal For Biologics: Breaking Through The Glass Ceiling Of Pharmaceutical Packaging
Source: Weiler Engineering, Inc.
By Bill Hartzel, SVP, Emergent BioSolutions and Andy Goll, President, Weiler Engineering, Inc.

As the industry continues its move toward biologics, innovative solutions and technologies will be needed to ensure a safe and reliable approach to the manufacturing and delivery of these drugs. One option is to leverage the advanced aseptic manufacturing of blow-fill-seal (B/F/S) technology, which has the potential to address the challenges of traditional glass filling as well as the global distribution of biologics.
access the White Paper!
Log In
Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue.
X
Enter your credentials below to log in. Not yet a member of Pharmaceutical Online? Subscribe today.
Subscribe to Pharmaceutical Online
X
Subscribe to Pharmaceutical Online
Weiler Engineering, Inc.
This website uses cookies to ensure you get the best experience on our website. Learn more